Single session EUS-ERCP in the management of pancreatic cancer: experience in a tertiary referral center in Greece
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S354
DOI: 10.1055/s-0044-1783567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von V. Papastergiou und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) and endoscopic retrograde cholangiopancreatography (ERCP) are complementary procedures, increasingly performed in a single session under one single sedation. This study was aimed to evaluate the procedural outcomes of single-session EUS+ERCP and its impact on length of hospitalization in pancreatic cancer patients.
Methods
We retrospectively evaluated a prospectively maintained EUS-ERCP database, (January 2022-July 2023). From January 2023 onwards, patients with an indication for both EUS and ERCP were preferentially booked for a single-session procedure, subjected to slot availability. Consecutive pancreatic cancer patients were analyzed, subdivided into three groups: Group-A (single-session EUS+ERCP), Group-B (undergoing both EUS and ERCP, performed in separate sessions during their hospitalization) and Group-C (undergoing only EUS or only ERCP). The following outcomes were analyzed: 1) technical success of EUS-FNB tissue acquisition, 2) technical success of ERCP-guided biliary stenting, 3) rates of overall adverse events and 4) length of hospitalization.
Results
A total of 114 patients were included (55.4% males, mean age 72.4 years), of whom 30 (26.3%) in Group-A, 30 (26.3%) in Group-B and 54 (47.4%) in Group-C (only EUS, n=28; only ERCP, n=26). EUS preceded ERCP in all patients in Groups A and B. No statistically significant differences were detected concerning rates of successful EUS-FNB tissue acquisition (Group-A: 90%, Group-B: 93.3%, Group-C: 100%, p=0.25) successful ERCP-guided biliary stenting (83.3%, 86.7% and 85.2% respectively, p=0.94) and the overall rates of adverse events (3.3%, 10% and 3.7% respectively, p=0.39) among the three study groups. The median length of hospitalization was significantly shorter in Group-A (2 days, range:1-3) compared to Group-B (3 days, range: 1-35) (p=0.046).
Conclusions
A single session EUS+ERCP approach is similarly effective and safe, whereas it significantly reduces hospitalization duration, as compared to that of the procedures performed separately. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Papastergiou, V., Varytimiadis, K., Mylonas, I., Archavlis, E., Koustenis, K. R., Almpani, F., Veretanos, C., Georgiadi, T., Kozompoli, D., Patsi, M., Kalogiros, G., Provi, D., Mousourakis, K., Christidou, A., Mela, M., Katopodi, K., Chatzievangelinou, C., Vienna, E., & Viazis, N. (2024). Single session EUS-ERCP in the management of pancreatic cancer: experience in a tertiary referral center in Greece. Endoscopy, 56(S 02 S 02), S354. https://doi.org/10.1055/s-0044-1783567
Vancouver
Papastergiou V, Varytimiadis K, Mylonas I, Archavlis E, Koustenis KR, Almpani F, et al. Single session EUS-ERCP in the management of pancreatic cancer: experience in a tertiary referral center in Greece. Endoscopy. 2024;56(S 02 S 02):S354. doi:10.1055/s-0044-1783567
BibTeX
@article{Papastergiou2024,
author = {Papastergiou, V. and Varytimiadis, K. and Mylonas, I. and Archavlis, E. and Koustenis, K. R. and Almpani, F. and Veretanos, C. and Georgiadi, T. and Kozompoli, D. and Patsi, M. and Kalogiros, G. and Provi, D. and Mousourakis, K. and Christidou, A. and Mela, M. and Katopodi, K. and Chatzievangelinou, C. and Vienna, E. and Viazis, N.},
title = {Single session EUS-ERCP in the management of pancreatic cancer: experience in a tertiary referral center in Greece},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S354},
doi = {10.1055/s-0044-1783567}
}
EUVIMED